Receptors, Corticotropin-Releasing Hormone, antagonists & inhibitors
- Name
- Receptors, Corticotropin-Releasing Hormone, antagonists & inhibitors
- Accession Number
- DBCAT003072
- Description
Not Available
- Drugs
Drug Drug Description Verucerfont Verucerfont has been used in trials studying the treatment of Congenital Adrenal Hyperplasia. - Drugs & Drug Targets
Drug Target Type